Invest in Stocks of Moderna, Verizon and Nike from only $500 on eToro

The S&P500 breaks above 4000 for the first time ever

US major stock markets continue to be driven by a bullish interest even if on Tuesday they had all moved in red territory.

The Nasdaq100, the S&P500, and the Dow Jones Industrial Average had moved upwards in the past two consecutive weeks and are higher at this point in the current one.

The S&P500 and the DJIA have moved to new all-time high levels, while the tech-driven Nasdaq is fighting its way towards previous all-time high levels.

The stock markets may have been supported by a weaker USD in the latest daily sessions.

This report will be focusing on some of the most important stock movers that made headlines in the past days.

Invest in Stocks on eToro

Can Nike see a boom in sales with pandemic end?

Nike Inc. (Nike) was the top winner for the Dow Jones on Tuesday gaining +1.51% and closing at $137.16.

Even though its recent close is not far away from its 52-week high price at $147.95 seen on the 21st of December, the company is down -3.06% on a year-to-date basis.

In its quarterly earnings report for the period ending February 28th of 2021, some challenges were presented that may need to be addressed at this point.

North American sales were down 10 percent due to supply challenges that may have slowed down the arrival of inventory.

Such challenges may have surfaced with circumstances created by the pandemic.

Furthermore, some Nike stores also suffered closures with pandemics again impacting revenues downwards.

Despite these recent challenges the company represents one of the most valuable and recognizable brands in the world.

According to the increasing revenue data seen prior to the pandemic, expectations remain very high for the world-known apparel company.

Pre pandemic sales grew for consecutive quarters in China, North America, and Europe.

With the mass vaccination process carried out so far and expected to continue extensively until the end of the year, the pandemic is possibly fading away, favoring Nike.

We could expect that the improved health and economic circumstances especially in China and the US, could contribute to a rise in revenues for Nike

Invest in Stocks of Nike on eToro

Verizon aims to expand 5G network

Verizon Communications Inc. (#VZ) was also on the winner’s list of the Dow Jones on Tuesday even though it did not head it.

Verizon moved higher by the minor +0.41% and closed the session at $59.11.

Verizon has moved higher in March and is just nearby its 52-week high price of $61.95 reached back on the 2nd of December.

In the past few days, Verizon announced further cooperation with Amazon Web Services (#AMZN).

Even though their cooperation with Amazon is focused on 5G networks their new aim is to provide private mobile edge computing (MEC).

This infrastructure enables ultra-low latency, higher levels of security, and deeper customization.

Moreover, Verizon also announced the use of signal repeaters from FRTek and SureCall that will support increased 5G Ultra-Wideband coverage to its customers.

Both the headlines were delivered on Tuesday probably putting VZ, in the main focus for traders.

Finally, it would be useful to note that on the 8th of April, Verizon will trade ex-dividend for its

respective upcoming dividends. Verizon is expected to remain in markets focus also in the next weeks as on the 21st of April it will be releasing its earnings report for the Q1 2021.

Invest in Stocks of Verizon on eToro

Moderna’s vaccine under demand

Moderna’s share rose by +2.79% on Tuesday closing the session at $133.53.

No need to mention how much value Moderna is offering the world at this very difficult moment.

On a year-to-date basis Moderna’s, the share price is up +27.82% even though it has moved gradually lower since February.

In the most recent days, the UK began using Moderna’s COVID-19 vaccine specifically in Wales.

Furthermore, the EU was happy to find that the number of doses promised by Moderna is on track to be met.

Different parts of the world are now turning to Moderna, as other vaccine developers like AstraZeneca are stalling with manufacturing problems.

More directly Pfizer’s (#PFE) and Moderna’s vaccines could be the most sought after at this stage.

As the pressure and demand for more vaccines globally are building up the FDA authorized Moderna to provide more doses per package sent.

Initially, they provided a multiple-dose vial with a maximum of 11 doses and the number has now been increased to 15.

Moreover, the FDA increased the time available for the doses to be kept at room temperature to 24 hours, up from the previously authorized 12 hours.

The news seems to confirm traders’ bullish appetite for Moderna, as the world’s economic and health recovery seems to depend on such companies at the moment.

Invest in Stocks of Moderna on eToro